Story by Lauren Woods at UConn Health
A leading edge immunotherapy clinical trial at UConn Health’s Carole and Ray Neag Comprehensive Cancer Center has packed a one-two punch successfully controlling a patient’s advanced lung cancer using the combined power of two immunotherapy drugs.
For 50 years Michel Gueret, 67, of Canton was a heavy smoker. That is until May 2012 when he received the devastating news that he had advanced lung cancer while hospitalized for a collapsed lung at UConn John Dempsey Hospital.
“I remember Michel in his hospital bed following discovery of his large lung cancer tumor,” recalls his oncologist, Dr. Jeffrey Wasser. “He was very thin, barely able to walk and was having trouble breathing. I was afraid that his lifespan would be severely reduced as his large tumor consumed a large portion of his lung which impaired his ability to walk and making surgery to remove it impossible.”